News
Report urges pharma companies to utilise synthetic data in clinical trials
A new report from Phesi and Accenture is encouraging pharmaceutical companies to utilise synthetic data in clinical trials.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
A new report from Phesi and Accenture is encouraging pharmaceutical companies to utilise synthetic data in clinical trials.